Session I: Clinical Genomics

Clinical Genomics

In session I of Myeloma2018, Suzanne Trudel, MD, FRCPC, Jens Lohr, MD, PhD, Angela Dispenzieri, MD, Ola Landgren, MD, PhD, and Daniel AuClair, PhD, provide updates on important, non-invasive genome profiling techniques to determine key markers in patients with multiple myeloma. Clinical trial results are discussed, as are the effectiveness of techniques such as cell-free disease assessment, MRD testing, and V(D)J based MRD tracking.